Robotic Assisted Balance and Exoskeleton Training (REACTION) in Neurorehabilitation: a Feasibility Study
REACTION
2 other identifiers
interventional
20
1 country
2
Brief Summary
The goal of this clinical trial is to explore the effect on walking speed of a new robotic assisted balance and gait trainer (REACTION) and their subsystems in individuals with neurological disorders. The study will provide insight in the feasibility of REACTION. Participants will:
- Participate in two sessions in which every session contains a walking task and balance tasks
- end the study with a semi-structured interview
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Apr 2025
Shorter than P25 for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedFebruary 12, 2025
February 1, 2025
9 months
January 16, 2025
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Walking speed
The walking speed of the participants during a 6.5 meter walk.
1 week
Secondary Outcomes (4)
Kinematic data
1 week
Short Form Berg Balance Scale (SFBBS)
1 week
DON/DOFF
1 week
Level of Assistance
1 week
Study Arms (1)
Experimental arm
EXPERIMENTALInterventions
Eligibility Criteria
You may not qualify if:
- A potential participant who meets any of the following criteria will be excluded from participation in this study:
- Premorbid disability of lower extremity
- Progressive neurological diseases like dementia or Parkinson
- Skin lesions or severely impaired sensation at the hemiparetic leg
- Contraindication for mobilization, like lower limb fracture
- Insufficient knowledge of the Dutch language to understand the purpose or meth-ods of the study
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Roessingh Research and Developmentlead
- Sint Maartenskliniekcollaborator
Study Sites (2)
Roessingh Research and Development
Enschede, Netherlands
Sint Maartenskliniek
Ubbergen, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2025
First Posted
February 3, 2025
Study Start
April 1, 2025
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
February 12, 2025
Record last verified: 2025-02